Navigation Links
BioMed Realty Trust Reports Third Quarter 2008 Financial Results
Date:10/29/2008

7,665 58,525 54,556

General and

administrative 4,589 5,283 16,428 15,990

Total expenses 49,885 40,816 136,246 125,868

Income from

operations 30,926 24,016 82,694 76,192

Equity in net loss

of unconsolidated

partnerships (208) (261) (338) (694)

Interest income 110 239 370 809

Interest expense (13,035) (7,043) (28,600) (21,013)

Income from

continuing

operations

before minority

interests 17,793 16,951 54,126 55,294

Minority interests

in continuing

operations of

consolidated

partnerships (11) 51 (4) (61)

Minority interests in

continuing

operations of

operating

partnership (559) (545) (1,767) (1,821)

Income from

continuing

operations 17,223 16,457 52,355 53,412

Income from

discontinued

operations before

(loss)/gain on sale

of assets and

minority interests - - - 639

(Loss)/gain on sale

of real estate assets - (1) - 1,087

Minority interests

attributable to

discontinued

operations - - - (74)

(Loss)/income

from

discontinued

operations - (1) - 1,652

Net income 17,223 16,456 52,355 55,064

Preferred stock

dividends (4,241) (4,241) (12,
'/>"/>

SOURCE BioMed Realty Trust, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
2. BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends
3. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
4. Verax Biomedical Receives 510 (k) Clearance from FDA for Platelet PGD Test
5. SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market
6. NCIIA Announces Launch of 4th Annual Student Biomedical Innovation Competition
7. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
8. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
9. Crux Biomedical Announces First Successful U.S. Implant of Its New Retrievable Inferior Vena Cava (IVC) Filter
10. Environmental Tectonics Corporations BioMedical Division Announces New Contract
11. Avery Biomedical Devices, Inc. Appoints Elefteriades to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013 PuraMed BioScience ® ... marketer of over-the-counter (OTC) medicinal and healthcare products, ... on the company based on low market capitalization ... Non-Prescription, All Natural Product to Treat Migraine Headaches ... #1 Prescription Competitor , Currently Available Nationwide ...
(Date:5/23/2013)... Calif. , May 23, 2013  Saddleback Memorial ... recently became the first hospital on the West ... technology. This new surgical option provides women with a ... Marc Winter , M.D., a ... and surgeon and medical director of minimally invasive surgery ...
(Date:5/23/2013)... Md. , May 23, 2013 Northwest ... biotechnology company developing DCVax ® personalized immune therapies ... use its exhibit at this year,s American Society Of ... to highlight its leadership role in immune therapy.  ... The ASCO annual meeting is the pre-eminent conference focused ...
(Date:5/23/2013)... May 23, 2013 Pusan National University ... private biotherapeutics and contract research company focused on ... cancer, announced today a publication reporting the induction ... the oncolytic and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; ... published in the May 15 th , 2013 ...
Breaking Biology Technology:PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3
... the investment manager of Xmark Opportunity Fund, L.P. and Xmark Opportunity Fund, Ltd., sent the following letter to the Board of Directors of ... XMARK OPPORTUNITY PARTNERS, LLC, ... 90 Grove Street, ... Suite 201, ...
... pro-t-action(TM) product based on probiotic microorganismsActive ingredient easily integrated ... introduced at International Association of Dental Research annual conference ... April 1-4 LUDWIGSHAFEN, Germany and MIAMI, April 1 ... of tooth decay affecting an estimated 5 billion people ...
... CALGARY, April 1 /PRNewswire-FirstCall/ - SemBioSys Genetics ... high-value proteins and oils in plant seeds, ... recombinant human insulin program. In December 2008, ... non-refundable option to license rights to SemBioSys, ...
Cached Biology Technology:Xmark Requests That Icagen Oust Its CEO and Pursue Strategic Alternatives, and Calls on Board Members to Resign 2BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth 2BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth 3BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth 4BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth 5SemBioSys provides update on insulin program 2SemBioSys provides update on insulin program 3
(Date:5/24/2013)... Frontiers, one of the world,s largest and fastest growing ... journal, Frontiers in Physics . , A broad ... will provide an open-science and interactive web platform ... rigorously peer-reviewed articles. , Frontiers, real-time and interactive ... range of article types. With an average of three ...
(Date:5/24/2013)... In the search for medication against Alzheimer,s disease, scientists have ... break down Amyloid beta (A-beta). After all, it is the ... brains of Alzheimer,s patients. Starting point for the formation of ... were the first to unravel the function of APPL ... healthy fruit flies. , Alessia Soldano (VIB/KU Leuven): "We ...
(Date:5/23/2013)... ships per year, carrying more than 284 million tons of ... billion dollars in toll fees for the Panama Canal Authority. ... gallons of water are used from Gatun Lake, which is ... living in the isthmus. , However, the advent of ... of the ships at sea, has demanded change. The Panama ...
Breaking Biology News(10 mins):Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3A new strategy required in the search for Alzheimer's drugs? 2Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3
... of Health has renewed a five-year research grant for ... group lead by David G.I. Kingston, University Distinguished Professor ... known internationally for his work in biodiversity and development ... on Biological Diversity, he will share a portion of ...
... 2008) For medical students who spend years ... concepts, it can be rather intimidating to prepare for ... The third edition of a best-selling book that ... Clinical Skills for OSCEs , was recently released ...
... (GSA) is proud to acknowledge the work of 12 ... foster new ideas, recognize leadership in gerontological teaching and ... The award presentations will take place at GSA,s 61st ... 21-25, 2008, in National Harbor, MD , at ...
Cached Biology News:Chemist to donate potential pharmaceutical royalties to Madagascar 2New book helps medical students master clinical skills 2GSA congratulates 2008 award winners 2GSA congratulates 2008 award winners 3
XPC Immunogen: XPC (NP_004619, 141 a.a. ~ 251 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rabbit polyclonal to Lck (phospho Y192) ( Abpromise for all tested applications). entrezGeneID: 3932 SwissProtID: P06239...
Anti 7H6 Antigen (tight-junction associated protein Antigen) Monoclonal Antibody 7H6...
Goat polyclonal to Ephrin B2 ( Abpromise for all tested applications). entrezGeneID: 1948 SwissProtID: P52799...
Biology Products: